Navigation Links
Dr. Philip Katz Elected President of the American College of Gastroenterology
Date:10/21/2009

p>Dr. Katz is a practicing clinician with active teaching and editorial positions. In addition to lecturing on many gastroenterology-related topics, Dr. Katz is an editorial reviewer for numerous journals including Annals of Internal Medicine, American Journal of Gastroenterology, Gastroenterology, and Alimentary Pharmacology and Therapeutics. He has contributed to the publication of over 140 peer-reviewed papers, as well as numerous abstracts, books, book chapters, and monographs.

Dr. Katz has played an instrumental leadership role in the ACG, particularly as an educator. A member of the Board of Trustees since 2001, Dr. Katz has served as Treasurer and Vice President of the College. His generous contributions of time, effort and creativity to the College encompass service as a member of the Educational Affairs Committee beginning in 1995, and serving as Chair from 1996 to 1999. He served as Course Director of ACG National Postgraduate Course in 2000. He pioneered the "What's New in GI Pharmacology?" course and has been involved since its inception in 1999. Dr. Katz has served as ACG's representative to the American Board of Internal Medicine and has been actively involved in the collaborating with ABIM and his ACG colleagues to establish appropriate criteria for gastroenterology training and Board recertification.

Dr. Katz was a driving force behind the development and launch of the ACG "Education Universe," an innovative, online educational portal offering a library of ACG educational activities. He also helped to envision the GI Training pathway within the ACG Education Universe as a resource to GI Program Directors and fellows-in-training in gastroenterology.

Over the years, Dr. Katz has been deeply involved in programs targeted to GI trainees. "I believe these fellows forums are invaluable in helping to train the clinicians of tomorrow and to create a bond between the College and its future membership," com
'/>"/>

SOURCE American College of Gastroenterology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
2. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
3. Audio from Medialink and Philips: Americas Dirty Mouths
4. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
5. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
6. North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign
7. Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
8. Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use
9. Philip Coelho Joins Mediware Board
10. VIDEO from Medialink and Philips: Philips Electronics Unveils First Imagination Light Canvas at the New Mercy Medical Center in Rogers AR
11. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... WASHINGTON, D.C. November 18, 2009 -- When peopl...parasites, which enter the body from the saliva of...pread to red blood cells. Inside the blood cells, ...dhesive proteins on the cell surface that change t.... , Experiments show that infected red blood cel...
(Date:11/22/2009)... HealthSmart, an innovative...nced that it has successfully completed a recapita...ompany’s other lenders. Silver Point Capita...nwich, Connecticut. This recapitalization allows ...ts business strategy. , , ...
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNewswi... statement after the Senate voted to begin full de..., (Logo: http://www.newscom.com/cgi-bin/prnh/2008...ther historic step on the road to enacting health ...l hurdle, senators will now have an opportunity to...
(Date:11/21/2009)..., , LONDON, November 21, 2009 /PRNewswire-...est Test Test Test Test Test Test Test Test Test T...est Test Test Test Test Test Test,Test Test Test T... More test More test More test More test More ...test More test More test More test More test More,...
(Date:11/21/2009)... New Haven Dental Group mer... D.D.S of Branford, CT. , ... Group, comprised of partners Dr. David Gibson, Dr... Forrester has just merged their growing practice ...man., , ,When Dr. Pickman decided he wanted to ret...
Breaking Medicine News(10 mins):Health News:Measuring and modeling blood flow in malaria 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:New Haven Dental Group Expands Their Vision 2
...mory Crawford Long Hospital is the only site in th...rtain voice disorders that in the past might have...sium-titanyl-phosphate (KTP) laser, the device use...ews for those singers, teachers, lawyers and const...
...ealth authorities in the US are worried about yet ...squito-spread infection. Rudy Bueno, the Ch...aid that the situation may worsen if people don't ...pellants or going out at night in short-sleeve shi...
...ark Ridge, Ill. "Every second counts for anesthesi... known as malignant hyperthermia (MH)." Accordin...of the American Association of Nurse Anesthetists,...t is used to prepare the DS for use. Malig...
...ouths who receive more than 10 a week in spending ...likely to become 'problem drinkers', a survey of ...is from Liverpool John Moores University and colle...ing alcohol, of which 38% binged, 24% drank freque...
...mmonia gas leaked from the state-owned Fertilisers...al near here late Thursday, causing breathing pro...r the leak had been rectified. FACT offici...reathe. TV reporters who arrived at the sc...
...eople who use Swedish moist snuff (snus) run twice...is is the main result of a follow-up study conduct...lmost 300,000 male construction workers. The study...is an unusually malignant form of the disease. Sin...
Other Medicine News:Health News:New Laser Offers Alternative to Surgery in Treating Voice Disorders 2Health News:Health Authorities Fear West Nile Season Again in US 2Health News:Research Reveals Way to Speed Up Treatment of Deadly Malignant Hyperthermia 2Health News:Use of Swedish 'snus' is Linked to a Doubled Risk of Pancreatic Cancer 2
(Date:11/20/2009)...wswire/ -- Reportlinker.com announces that a new m...e. ,, Pipettes & Pipettors - A Global Mark...m/p0164373/Pipettes--Pipettors---A-Global-Market-P...um=pr&utm_campaign=prnewswire ,, Pipettes...any research laboratory. Large-scale applications ...
(Date:11/20/2009)...Nov. 20 Boston Scientifi...it has received 510(k) clearance from the U.S. Foo...al to market its WallFlex® Fully Covered Esop...geal strictures (obstructions) caused by tumors in...geal cancer. ,, (Photo: http://www.newscom.c...
(Date:11/20/2009)...Newswire-FirstCall/ -- Smith & Nephew ( SNN, L...ce the signing of a technology development contrac...t may lead to the creation of a fracture fixation ...the limbs of soldiers who sustain battlefield inju...ch Projects Agency (DARPA), the central research a...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 1Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 2Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 3Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 1Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 2Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 3Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 1Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 2Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 3
... 2007 - ACADIA Pharmaceuticals,Inc. (Nasdaq:ACAD) ... Phase II schizophrenia co-therapy trial with ACP-...erse agonist. The trial,evaluated ACP-103 co-thera...ommonly prescribed atypical antipsychotic drug, or.... The co-therapy,arms with ACP-103 demonstrated st...
...ire-FirstCall/ -- La Jolla,Pharmaceutical Company ... data for the Phase 3 trial of Riquent(R) (abetimu...rythematosus,("lupus" or "SLE"). The updated analy...s a definitive and significant dose response,betwe...compared,with placebo (p=0.0001). These interim da...
Other Medicine Technology:Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 2Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 3Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 4Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 5Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 6La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: